Aurinia Pharmaceuticals Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $21.0M | $57.0M | $39.6M |
| FY2017 | $11.9M | $189.8M | $165.6M |
| FY2018 | $10.1M | $145.9M | $118.0M |
| FY2019 | $25.7M | $324.3M | $306.0M |
| FY2020 | $55.9M | $463.7M | $272.4M |
| FY2021 | $64.3M | $543.4M | $231.6M |
| FY2022 | $65.4M | $470.9M | $94.1M |
| FY2023 | $170.1M | $548.1M | $48.8M |
| FY2024 | $173.2M | $550.6M | $83.4M |
| FY2025 | $170.3M | $751.6M | $80.2M |